DNA sequencers from Chinese firm MGI Tech can rival those from global market leader Illumina in spite of US sanctions, according to Yin Ye, CEO of BGI Group, former parent of the Shenzhen-based biotech company.MGI’s sequencers offer the best “comprehensive value” in terms of time, quality and cost, Yin said in an interview on the sidelines of the BioHK 2025 conference on Thursday.Yin, 46, pointed out that MGI’s latest product, the DNBSEQ-T7+, is “pushing physics and chemistry to the limit”, as...